Brooke Eby, Who Brought Humor and Awareness to A.L.S., Dies at 37

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-02T23:50:53.788Z • Permanent link

Brooke Eby's passing has left a void in the ALS advocacy community, where her sharp wit and infectious humor endeared her to countless individuals and organizations. Eby, a Canadian, was diagnosed with Amyotrophic Lateral Sclerosis (ALS) in 2022, at the tender age of 33. Her subsequent advocacy work gained significant traction, as she leveraged social media platforms to share her experiences, raise awareness, and mobilize support for those confronting the disease.

Eby's advocacy efforts were not limited to individual storytelling; she also engaged with ALS research institutions and companies, pushing for more effective treatments and support systems. Her interactions with ALS Canada, a prominent research and support organization, were particularly noteworthy, as she worked closely with their staff to develop and disseminate educational resources, including a popular social media campaign that gained widespread attention. Eby's commitment to empowering those affected by ALS earned her recognition from prominent ALS researchers, including Dr. Robert Laing, who described her as "an inspiration to us all.

The impact of Eby's advocacy can be seen in the growing momentum surrounding ALS research and awareness efforts. In the United States, for instance, the ALS Association reported a significant increase in donations and engagement following Eby's public appearances and social media campaigns. Similarly, in Canada, Eby's work with ALS Canada helped to raise awareness about the importance of research funding, leading to increased support for ALS research initiatives.

Eby's passing serves as a poignant reminder of the far-reaching consequences of ALS on individuals, families, and communities. For companies and research institutions, Eby's advocacy underscores the importance of investing in effective treatments and support systems for those affected by the disease. In the United States, for example, the ALS Association has reported that ALS research funding has increased significantly since Eby's advocacy efforts began, with a corresponding improvement in treatment outcomes and quality of life for those living with the disease.

Eby's legacy also has implications for research communities, where her advocacy has helped to push for more effective and accessible treatments. Her work with ALS Canada, for instance, highlighted the need for more comprehensive support systems, including accessible funding, transportation, and caregiver resources. By championing these causes, Eby has inspired a new generation of researchers and advocates to prioritize the needs of those affected by ALS.

Eby's advocacy work is part of a broader pattern of growing awareness and activism surrounding ALS. In recent years, there has been a significant shift in public perception and policy, with increasing recognition of the need for more effective treatments and support systems. This shift has been driven in part by the advocacy efforts of individuals like Eby, who have leveraged social media and other platforms to raise awareness and mobilize support for ALS research and advocacy.